Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 07, 2025
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science Limited held its 34th Annual General Meeting on August 7, 2025, via Video Conferencing, and has now submitted the Scrutinizer's report along with voting results. All 5 resolutions on the agenda were passed by shareholders with the required majority, with overall approval ranging between 99.44% and nearly 100%. The resolutions covered: (1) adoption of audited financial statements for FY25, (2) declaration of a final dividend for FY ended March 31, 2025, (3) re-appointment of Mr. Aditya Arun Kumar as a Director, (4) appointment of M/s V. Sreedharan & Associates as Secretarial Auditor, and (5) remuneration of M/s Rao, Murthy & Associates as Cost Auditors for FY 2025-26. About 65% of total outstanding shares (roughly 5.99 crore out of 9.22 crore shares) participated in the voting, with 513 members voting via e-voting and 15 voting at the meeting.
This is a routine post-AGM regulatory filing confirming shareholder approval of routine items, including a final dividend for FY25. No new business or material strategic decision was approved, so the impact on the stock price is expected to be neutral. Shareholders can look out for the dividend record/booklet dates and payment timeline announced separately by the company.